Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2014-06-03 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARBENT (01100), Ain
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LA PHARMACIE DU GEANT : revenue, balance sheet and financial ratios
LA PHARMACIE DU GEANT is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARBENT (01100),
this company of category PME
shows in 2025 a net income positive of 245 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LA PHARMACIE DU GEANT (SIREN 802638486)
Indicator
2025
2024
2023
2022
2021
2020
2019
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
244 821 €
103 919 €
72 356 €
236 919 €
168 117 €
99 107 €
15 891 €
112 864 €
145 577 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, LA PHARMACIE DU GEANT generates positive net income of 245 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 146 k€ -> 245 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
244 821 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
79.116%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.352%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LA PHARMACIE DU GEANT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
2025
Debt ratio
391.98
247.063
366.89
277.808
203.12
164.986
178.343
126.677
79.116
Financial autonomy
18.065
25.935
18.893
22.824
28.037
30.907
28.647
32.62
42.352
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
79.122025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-16 pts over 3 years
In 2025, the debt ratio of LA PHARMACIE DU GEANT (79.12) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.35%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+11 pts over 3 years
In 2025, the financial autonomy of LA PHARMACIE DU GEANT (42.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 199.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
199.876
Liquidity indicators evolution LA PHARMACIE DU GEANT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
179.793
191.836
181.237
196.137
205.446
221.458
193.191
169.021
199.876
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
199.882025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of LA PHARMACIE DU GEANT (199.88) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of LA PHARMACIE DU GEANT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of LA PHARMACIE DU GEANT is estimated at
3 889 010 €
(range 2 639 101€ - 6 102 393€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2639k€3889k€6102k€
3 889 010 €Range: 2 639 101€ - 6 102 393€
NAF 5 année 2025
Valuation method used
Net Income Multiple
244 821 €
×
15.9x
=3 889 011 €
Range: 2 639 101€ - 6 102 393€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare LA PHARMACIE DU GEANT with other companies in the same sector:
Frequently asked questions about LA PHARMACIE DU GEANT
What is the revenue of LA PHARMACIE DU GEANT ?
The revenue of LA PHARMACIE DU GEANT is not publicly disclosed (confidential accounts filed with INPI).
Is LA PHARMACIE DU GEANT profitable?
Yes, LA PHARMACIE DU GEANT generated a net profit of 245 k€ in 2025.
Where is the headquarters of LA PHARMACIE DU GEANT ?
The headquarters of LA PHARMACIE DU GEANT is located in ARBENT (01100), in the department Ain.
Where to find the tax return of LA PHARMACIE DU GEANT ?
The tax return of LA PHARMACIE DU GEANT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LA PHARMACIE DU GEANT operate?
LA PHARMACIE DU GEANT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart